Apr 28, 2020, 09:42 by

Imvax, Inc., a clinical-stage biotechnology company, today announced that Mark Exley, PhD, has been appointed as Chief Scientific Officer (CSO). Reporting to Imvax Chief Executive Officer (CEO) John Furey, Dr. Exley joins the company as it is developing Imvax’s lead product candidate, IGV-001, for the treatment of newly diagnosed glioblastoma multiforme (GBM).

Apr 28, 2020, 09:41 by

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that EPS, a Tokyo based CRO, have entered into an agreement with CluePoints to offer Risk Based Quality Management (RBQM) solutions to its sponsors to drive early risk detection, improve quality and enhance patient safety in a cost-effective and resource-efficient manner.

Apr 28, 2020, 09:41 by

AI powered ‘digital twins’, using PharmaPendium data, will help physicians improve dosing of COVID-19 therapies with personalized model simulations

Apr 28, 2020, 09:40 by

TailorMed today launched the Remote Navigation solution as part of its unique and industry-leading financial navigation solution. It is the first of its kind to enable healthcare providers and their staff to remotely work with patients to ease the patient's and hospital's financial burden. The new product also helps healthcare providers quickly access TailorMed's much larger suite of financial navigation technology and services currently available to TailorMed's 50 client hospitals and medical practices.

Apr 28, 2020, 09:40 by

SGS Digicomply has announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding ways to respond to the COVID-19 pandemic.

Apr 28, 2020, 09:40 by

Panthera opens for clinical trials in Manchester, its second clinical trial site in the UK, with additional health and safety precautions to protect staff and patients from COVID-19.

Apr 28, 2020, 09:40 by

Apr 28, 2020, 09:40 by

Intuitive COVID-19 Dashboard highlights patient compliance risks to protect study outcomes

Apr 28, 2020, 09:39 by

Apr 28, 2020, 09:39 by

Robust data strategy and improved technology infrastructure to accelerate drug development

Apr 28, 2020, 09:39 by

Patients monitor cardiac safety at home with easy-to-use, FDA-cleared KardiaMobile 6L personal ECG

Apr 28, 2020, 09:39 by

AMRI's Rensselaer, NY facility is the first in the industry to achieve Leader Status based on quantitative results of the Potent Compound Safety Certification program administered by SafeBridge.

Apr 28, 2020, 09:39 by

Apr 28, 2020, 09:39 by

The Elsevier Coronavirus Research Hub includes access to multiple tools, from scientific and clinical content to COVID-19 specific datasets, text mining services and more

Apr 28, 2020, 08:23 by User Not Found

Clinical Research News | A growing body of research points to the potential of gut microbes as markers for early diagnosis of severe illnesses, including colon cancer. For researchers with the Bellvitge Biomedical Research Institute and Catalan Institute of Oncology in Barcelona, the collection of gut microbiome data is just the starting point for the vast statistical stew they’ll eventually be mining for answers.

Apr 24, 2020, 09:16 by User Not Found

Clinical Research News | As world governments continue to address the spread of COVID-19, the clinical research community is looking for ways to manage and treat for the virus as well. Recent efforts include studies related to children infected with the virus, a COVID-19 convalescent plasma study, and much more.

Apr 23, 2020, 10:35 by User Not Found

Clinical Research News | Medable has announced a multi-company research framework to accelerate development of diagnostics and treatments for COVID-19. The ACCESS initiative—American COVID-19 Collaborative Enabling Seamless Science—provides a mobile consumer application and secure infrastructure to quickly connect millions of home-bound Americans with health researchers and clinical trial teams.

Apr 21, 2020, 14:03 by User Not Found

Clinical Research News| Study sponsors are facing an unprecedented level of clinical supply disruptions caused by the COVID-19 pandemic. We spoke to Barry Moore of 4G Clinical for insights on the current struggles of clinical supply study managers, innovations being deployed and ways to build a more resilient supply chain for future trials.

Apr 17, 2020, 08:27 by User Not Found

Clinical Research News | The clinical research community continues to aggressively research and innovate for SARS-CoV-2 solutions. The latest this week includes many COVID-19 trials, patient registries, PPE exchanges, and much more.

Apr 16, 2020, 11:21 by User Not Found

Clinical Research News| In our pell-mell race to learn more about the SARS-CoV-2 virus and how best to treat the disease it causes, researchers all over the world are exploring how blood plasma from patients who have tested positive for SARS-CoV-2 might help others who are sick.